In conclusion, our study demonstrates that microglial CD2AP deficiency protects against disease-like phenotypes in AD mice, revealing a novel role of CD2AP in regulating microglial functions and their responses to Aβ toxicity in AD. This evidence concerns the gene CD2AP and Alzheimer disease.